Seeing Nonmelanoma Skin Cancers Through a New Lens - The Role and Place of Immunotherapy
2022
Pearls on the current concepts in diagnosis and management of NMSC
Event
Satellite Symposium at the European Association of Dermato Oncology 2022, Sevilla Spain
Overview
Core topics include the identification of difficult-to-treat disease and evidence-based strategies for immunotherapy selection in cutaneous squamous cell carcinoma (CSCC) and basal cell carcinoma (BCC). To augment these insights, a patient panelist will highlight aspects of their own NMSC treatment journey via video commentary.
TOPICS TO BE DISCUSSED - Stratifying the Risk for Progression in NMSC
- Navigating Immunotherapy in Advanced CSCC
- Assessing the Role of Immunotherapy in Advanced BCC
This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.
Faculty 
This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement